MAPT and Alzheimer disease: Even though the hyperphosphorylation of tau is a transient, reversible physiological process, in neurodegenerative disorders such as AD, abnormal hyperphosphorylation of tau is resistant to dephosphorylation and proteolysis [666,667], often resulting in a 3–4-fold increase in accumulation compared to normal brains [668,669,670].